Sökning: onr:"swepub:oai:DiVA.org:umu-137406" >
A model using conco...
A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer
-
- Bersani, Cinzia (författare)
- Karolinska Institutet
-
- Mints, Michael (författare)
- Karolinska Institutet,Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden
-
Tertipis, Nikolaos (författare)
-
visa fler...
-
- Haeggblom, Linnea (författare)
- Karolinska Institutet
-
- Sivars, Lars (författare)
- Karolinska Institutet
-
Ährlund-Richter, Andreas (författare)
-
Vlastos, Andrea (författare)
-
Smedberg, Cecilia (författare)
-
Grün, Nathalie (författare)
-
- Munck-Wikland, Eva (författare)
- Karolinska Institutet
-
- Näsman, Anders (författare)
- Karolinska Institutet
-
- Ramqvist, Torbjörn (författare)
- Karolinska Institutet
-
- Dalianis, Tina (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- Elsevier, 2017
- 2017
- Engelska.
-
Ingår i: Oral Oncology. - : Elsevier. - 1368-8375 .- 1879-0593. ; 68, s. 53-59
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective: Head-neck cancer therapy has become intensified. With radiotherapy alone, 3-year disease-free survival (DFS) is 80% for HPV-positive TSCC/BOTSCC and better for patients with favorable characteristics, suggesting therapy could be tapered for some, decreasing side-effects. Therefore, we built a model to predict progression-free survival for patients with HPV-positive TSCC and BOTSCC. Material and methods: TSCC/BOTSCC patients treated curatively between 2000 and 2011, with HPV16 DNA/E7 mRNA positive tumors examined for CD8(+) TILs, HPV16 mRNA and HLA class I expression were included. Patients were split randomly 65/35 into training and validation sets, and LASSO regression was used to select a model in the training set, the performance of which was evaluated in the validation set. Results: 258 patients with HPV DNA/E7 mRNA positive tumors could be included, 168 and 90 patients in the respective sets. No treatment improved prognosis compared to radiotherapy alone. CD8(+) TIL counts and young age were the strongest predictors of survival, followed by T-stage <3 and presence of HPV16 E2 mRNA. The model had an area under curve (AUC) of 76%. A model where the presence of three of four of these markers defined good prognosis captured 56% of non-relapsing patients with a positive predictive value of 98% in the validation set. Furthermore, the model identified 35% of our cohort that was over-treated and could safely have received de-escalated therapy. Conclusion: CD8(+) TIL counts, age, T-stage and E2 expression could predict progression-free survival, identifying patients eligible for randomized trials with milder treatment, potentially reducing side effects without worsening prognosis.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Odontologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Dentistry (hsv//eng)
Nyckelord
- HPV
- Oropharyngeal cancer tonsillar cancer
- Base of tongue cancer
- Biomarkers
- Survival
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bersani, Cinzia
-
Mints, Michael
-
Tertipis, Nikola ...
-
Haeggblom, Linne ...
-
Sivars, Lars
-
Ährlund-Richter, ...
-
visa fler...
-
Vlastos, Andrea
-
Smedberg, Cecili ...
-
Grün, Nathalie
-
Munck-Wikland, E ...
-
Näsman, Anders
-
Ramqvist, Torbjö ...
-
Dalianis, Tina
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Odontologi
- Artiklar i publikationen
-
Oral Oncology
- Av lärosätet
-
Umeå universitet
-
Karolinska Institutet